首页> 中文期刊> 《中国卫生标准管理》 >分析纳洛酮治疗慢阻肺合并呼吸衰竭临床疗效

分析纳洛酮治疗慢阻肺合并呼吸衰竭临床疗效

         

摘要

Objective To study the clinical effect of the treatment of the patients with respiratory failure of chronic obstructive pulmonary complicated by naloxone. Methods According to the 2011 to 2013 in our hospital received 96 cases of chronic obstructive pulmonary disease with respiratory failure patients to research and analysis, these patients were divided into control group and observation group and the control group using conventional treatment, the observation group used routine treatment, naloxone treatment, the comparative analysis of two groups of patients with blood oxygen saturation and the effect of treatment. Results In the observation group, the clinical effective rate was 97.9% and the effective rate of the treatment in the control group was 81.3%, there is a difference in the two sets of Results (,P<0.05). Two patients with blood oxygen saturation were improved, the result is different (P<0.05). Observation group patients blood oxygen saturation degree increase compared with the control group,P<0.05. Conclusion The curative effect of naloxone on chronic obstructive pulmonary disease with respiratory failure patients more prominent, details of arterial blood gas in patients with improvement, so clinical can promote the use.%目的 研究分析慢阻肺合并呼吸衰竭患者接受纳洛酮治疗的临床效果.方法 根据2011~2013年我院接收的96例慢性阻塞性肺病合并呼吸衰竭患者来进行研究分析,将这些患者分成对照组和观察组,对照组使用常规治疗,观察组使用常规治疗和纳洛酮治疗,比较分析两组患者的血氧饱和度以及治疗效果.结果 观察组的临床中治疗有效率是97.9%,对照组的治疗有效率是81.3%,两组结果存在统计学差异性, P<0.05;两句患者的血氧饱和度均有所提升,结果具有差异性,P<0.05;观察组患者的血氧饱和度提升幅度比对照组大,P<0.05.结论纳洛酮对慢性阻塞性肺病合并呼吸衰竭患者的临床治疗效果比较突出,患者的动脉血气改善情况明显.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号